Close
Help




JOURNAL

Clinical Medicine Insights: Oncology

Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab

Submit a Paper


Clinical Medicine Insights: Oncology 2015:9 61-63

Case report

Published on 01 Jul 2015

DOI: 10.4137/CMO.S27142


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Oncology

Abstract

A 61-year-old man with relapsing-remitting multiple sclerosis developed extranodal large B-cell lymphoma of the stomach following monthly natalizumab infusions for 6 years. Development of lymphoproliferative disorders increases with chronic use of immunosuppression. Cases of primary central nervous system lymphoma as well as one case of peripheral T-cell lymphoma have previously been reported with natalizumab use. Given the absence of a known association between multiple sclerosis and extranodal presentations of diffuse large B-cell lymphoma, a causal association with natalizumab administration cannot be excluded.



Downloads

PDF  (646.66 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Clinical Medicine Insights: Oncology
testimonial_image
My experience publishing in 'Clinical Medicine Insights: Oncology' was excellent.  I was impressed with the quick review and proof-read processes.  The electronic submission website is user friendly, and the continuous manuscript status updates received from the journal were helpful in tracking the progress of the paper.
Dr Tallal Younis (Dalhousie Unversity, Halifax, Nova Scotia, Canada)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube